BEVA 2018
Back to Table of Contents
Add to My Library
Comments
Share:

Radiotherapy

Author(s):

A. Hollis

In: BEVA - Annual Congress - Birmingham, 2018 by British Equine Veterinary Association
Updated:
SEP 15, 2018
Languages:
Back to Table of Contents
Add to My Library

Radiotherapy has long been considered the ‘gold standard’ for the treatment of periocular sarcoids, with occasional case reports in the literature of the use of various forms of radiotherapy in other locations [1–5]. Low dose rate brachytherapy is no longer available in the UK because of the high cost of implants, the impracticality of treatments requiring isolation of the horse, alongside concerns for operator safety during the implantation and removal of radioactive sources from the horse. High dose rate brachytherapy (HDRB) has been successfully used in horses under routine standing sedation [6], although the technique is expensive and in the UK is ...

View full text
Back to Table of Contents
Add to My Library

Ask the author

0 comments
Submit

Affiliation of the authors at the time of publication

Centre for Equine Studies, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.

Copyright Statement

© All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.

Readers also viewed these publications

Provided by:

BEVA is a world-leading equine veterinary association committed to championing high standards of equine health and welfare. We advance the veterinary and allied sciences, promote scientific excellence and educate equine veterinary professionals throughout the world.
Run by a passionate group of equine vets, BEVA promotes and leads the equine veterinary community by providing a platform for discussion and an exchange of ideas on the management, health and welfare of the horse.

Learn more
Back To Top